Systematic review and meta‐analysis: importance of CagA status for successful eradication of Helicobacter pylori infection

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Alimentary Pharmacology and Therapeutics

• Publication date

  2006-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1365-2036.2006.02994.xPMID 16842453
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Meta‒Analysis in Stata™

  2008cited by this paper
• Smoking increases the treatment failure for Helicobacter pylori eradication.

  2006cited by this paper
• Systematic Review and Meta‐analysis: Proton Pump Inhibitor vs. Ranitidine Bismuth Citrate Plus Two Antibiotics in Helicobacter pylori Eradication

  2005cited by this paper
• From the authors

  2005cited by this paper
• Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial.

  2004cited by this paper
• Meta-analysis of the relationship between CagA seropositivity and gastric cancer.

  2004cited by this paper
• Helicobacter pylori CagA protein variation associated with gastric cancer in Asia

  2004cited by this paper
• Sequential treatment for Helicobacter pylori does not share the risk factors of triple therapy failure

  2004cited by this paper
• Meta-analysis of the relationship between cagA seropositivity and gastric cancer.

  2003cited by this paper
• Anti‐Helicobacter pylori therapy in India: Differences in eradication efficiency associated with particular alleles of vacuolating cytotoxin (vacA) gene

  2003cited by this paper
• Clinical and pathological implications of IgG antibody responses toHelicobacter pyloriand its virulence factors in non‐ulcer dyspepsia

  2003cited by this paper
• Helicobacter pylori strains and histologically‐related lesions affect the outcome of triple eradication therapy: a study from southern Italy

  2003cited by this paper
• Risk factors for failure of Helicobacter pylori therapy — results of an individual data analysis of 2751 patients

  2003cited by this paper
• Factors Associated With Treatment Failure of Helicobacter pylori Infection in a Developing Country

  2002cited by this paper
• Genotyping of Helicobacter pylori in paraffin-embedded gastric biopsy specimens: relation to histological parameters and effects on therapy

  2002cited by this paper
• Relevance of Underlying Disease and Bacterial vacA and cagA Status on the Efficacy of Helicobacter pylori Eradication

  2002cited by this paper
• Clinical outcome and influencing factors of a new short-term quadruple therapy for Helicobacter pylori eradication: a randomized controlled trial (MACLOR study).

  2002cited by this paper
• The effect of CagA status on response to Helicobacter pylori eradication therapy in Western Turkey.

  2001cited by this paper
• cagA Status and Eradication Treatment Outcome of Anti-Helicobacter pylori Triple Therapies in Patients with Nonulcer Dyspepsia

  2001cited by this paper
• Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia.

  2000cited by this paper
• Importance of Helicobacter pylori cagA and vacAstatus for the efficacy of antibiotic treatment

  2000cited by this paper
• CagA seropositivity and the severity of Helicobacter pylori infection in dyspeptic children.

  2000cited by this paper
• A whole-genome microarray reveals genetic diversity among Helicobacter pylori strains.

  2000cited by this paper
• Omeprazole or ranitidine bismuth citrate triple therapy to treat Helicobacter pylori infection: a randomized, controlled trial in Vietnamese patients with duodenal ulcer

  2000cited by this paper
• Duodenal Helicobacter pylori infection differs in cagA genotype between asymptomatic subjects and patients with duodenal ulcers.

  1999cited by this paper
• Metronidazole resistance and virulence factors in Helicobacter pylori as markers for treatment failure in a paediatric population.

  1999cited by this paper
• Lack of effect of treatment for Helicobacter pylori on symptoms of nonulcer dyspepsia.

  1999cited by this paper
• A systematic review of Helicobacter pylori eradication therapy—the impact of antimicrobial resistance on eradication rates

  1999cited by this paper
• Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia.

  1999cited by this paper
• Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia.

  1998cited by this paper
• Effect of Genetic Differences in Omeprazole Metabolism on Cure Rates for Helicobacter pylori Infection and Peptic Ulcer

  1998cited by this paper
• Antibody Response to Specific H. pylori Antigens in Functional Dyspepsia, Duodenal Ulcer Disease, and Health

  1998cited by this paper
• Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori.

  1998cited by this paper
• Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group.

  1998cited by this paper
• Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection.

  1997cited by this paper
• Effect of Helicobacter pylori eradication on gastritis in relation to cagA: a prospective 1-year follow-up study.

  1997cited by this paper
• Explaining heterogeneity in meta-analysis: a comparison of methods.

  1997cited by this paper
• cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors.

  1996cited by this paper
• Density of Helicobacter pylori infection in vivo as assessed by quantitative culture and histology.

  1996cited by this paper
• The interrelationship between cytotoxin-associated gene A, vacuolating cytotoxin, and Helicobacter pylori-related diseases.

  1996cited by this paper
• Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach.

  1995cited by this paper
• Operating characteristics of a rank correlation test for publication bias.

  1994cited by this paper
• Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer.

  1993cited by this paper
• Factors influencing the eradication of Helicobacter pylori with triple therapy.

  1992cited by this paper
• Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology.

  1991cited by this paper
• Helicobacter pylori infection and the risk of gastric carcinoma.

  1991cited by this paper
• Helicobacter pylori in patients with nonulcer dyspepsia.

  1991cited by this paper
• Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma.

  1991cited by this paper
• Meta-analysis in clinical trials.

  1986cited by this paper
• Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration.

  1984cited by this paper

• Rapid diagnosis and precision treatment of Helicobacter pylori infection in clinical settings

  2024cites this paper
• Relationship between antibiotic resistance and the cagA and vacA genotypes among Helicobacter pylori strain isolates from patients in Xi’an

  2023cites this paper
• Comparative Effectiveness of Various Eradication Regimens for Helicobacter Pylori Infection in the Northeastern Region of Poland

  2022cites this paper
• AGA Clinical Practice Update on The Management of Refractory Helicobacter pylori Infection: Expert Review

  2021cites this paper
• The Anti-Proliferative and Anti-Invasive Effect of Leaf Extracts of Blueberry Plants Treated with Methyl Jasmonate on Human Gastric Cancer In Vitro Is Related to Their Antioxidant Properties

  2020cites this paper
• Helicobacter pylori seroprevalence in six different ethnic groups living in Amsterdam: The HELIUS study

  2020cites this paper
• The Use of 13C-Urea Breath Test for Non-Invasive Diagnosis of Helicobacter pylori Infection in Comparison to Endoscopy and Stool Antigen Test

  2020cites this paper
• Chapter 4 Functional Dyspepsia and Helicobacter pylori Infection

  2019cites this paper
• High Prevalence of Antibiotic Resistance in Iranian Helicobacter pylori Isolates: Importance of Functional and Mutational Analysis of Resistance Genes and Virulence Genotyping

  2019cites this paper
• High prevalence of antibiotic resistance in Helicobacter pylori isolates from Iran: importance of functional and mutational analysis of resistance genes and virulence genotyping

  2019cites this paper
• Evaluation of diagnostic and treatment strategies for the management of Helicobacter pylori infection

  2019cites this paper
• Usefulness of rapid urease test samples for molecular analysis of clarithromycin resistance in Helicobacter pylori.

  2018cites this paper
• Can bacterial virulence factors predict antibiotic resistant Helicobacter pylori infection?

  2018cites this paper
• Helicobacter pylori antibody responses in association with eradication outcome and recurrence: a population-based intervention trial with 7.3-year follow-up in China

  2017cites this paper
• The association between vacA or cagA status and eradication outcome of Helicobacter pylori infection: A meta-analysis

  2017cites this paper
• Diagnostic Criteria in Peptic Ulcer Disease

  2017cites this paper
• Management of Helicobacter pylori Infection.

  2017cites this paper
• Clarithromycin Resistance Mutations in Helicobacter pylori in Association with Virulence Factors and Antibiotic Susceptibility of the Strains

  2016cites this paper
• The Influence of Iron Deficiency on Helicobacter pylori Eradication

  2016cites this paper
• Online Registry for Nationwide Database of Current Trend of Helicobacter pylori Eradication in Korea: Interim Analysis

  2016cites this paper
• Trends in Global Eradication Rates

  2016cites this paper
• Prevalence of cagA and vacA among Helicobacter pylori-infected patients in Iran: a systematic review and meta-analysis.

  2015cites this paper
• Elevated Serum anti-Helicobacter pylori

  2015cites this paper
• Factors Affecting First-Line Triple Therapy of Helicobacter pylori Including CYP2C19 Genotype and Antibiotic Resistance

  2014cites this paper
• The Problem of Helicobacter pylori Resistance to Antibiotics: A Systematic Review in Latin America

  2014cites this paper
• Virulence Factors and Antibiotic Resistance in Children With Helicobacter pylori Gastritis

  2014cites this paper
• Cost-effectiveness of screening and treating H. Pylori for gastric cancer prevention

  2014cites this paper
• Strategy for the treatment of Helicobacter pylori infection.

  2014cites this paper
• Chapter 20. Peptic Ulcer Disease

  2014cites this paper
• A erradicação do helicobacter pylori na actualidade e o problema da resistência

  2014cites this paper
• 12. Terapia de erradicación de Helicobacter pylori

  2014cites this paper
• Immune thrombocytopaenic purpura: an autoimmune cross-link between infections and vaccines

  2014cites this paper
• Choosing optimal first-line Helicobacter pylori therapy: a view from a region with high rates of antibiotic resistance.

  2014cites this paper
• Clinical relevance of Helicobacter pylori vacA and cagA genotypes in gastric carcinoma.

  2014cites this paper
• Principales indicaciones para el tratamiento de erradicación contra Helicobacter pylori y evaluación de tres esquemas de tratamiento

  2013cites this paper
• Functional Dyspepsia and Helicobacter pylori Infection

  2013cites this paper
• Cost-effectiveness of screening and treating Helicobacter pylori for gastric cancer prevention.

  2013cites this paper
• An Adaptive Evolution of Helicobacter pylori: Role of the CagA Presence in the Outcome of H. pylori Eradication in Children

  2013cites this paper
• Helicobacter and salmonella persistent infection strategies.

  2013cites this paper
• Monack Persistent Infection Strategies Salmonella and Helicobacter

  2013cites this paper
• Association of Helicobacter pylori dupA With the Failure of Primary Eradication

  2012cites this paper
• 8. Functional Dyspepsia: Pathophysiology and Treatment

  2012cites this paper
• The role of caga status on histological virulence, clinical presentation and eradication treatment outcomes in helicobacter pylori positive patients with functional dyspepsia

  2012cites this paper
• Randomized study of seven days of standard treatment for Helicobacter Pylori vs. ten days of standard treatment for Helicobacter Pylori with one year follow-ups of patients

  2012cites this paper
• Predicting Helicobacter pylori eradication: how to teach an old dog new tricks!

  2012cites this paper
• [109th Scientific Meeting of the Japanese Society of Internal Medicine: educational lecture: 8. Functional dyspepsia: pathophysiology and treatment].

  2012cites this paper
• Oxidative Stress Pathway Driven by Inflammation in Gastric Mucosa

  2011cites this paper
• Double-blind Randomized Trial of Quadruple Sequential Helicobacter pylori Eradication Therapy in Asymptomatic Infected Children in El Paso, Texas

  2011cites this paper
• CagA genotype and metronidazole resistant strain of Helicobacter pylori in functional dyspepsia in Thailand

  2011cites this paper
• Eficacia de la triple cura y su relación con el genotipo de Helicobacter Pylori Pacientes con dispepsia de la region centroccidental de Venezuela

  2011cites this paper
• Helicobacter pylori und gastroduodenales Ulkus Ein aktualisierter Kommentar der deutschen S3-Leitlinie

  2010cites this paper
• Clinical significance of Helicobacter pylori cagA and iceA genotype status.

  2010cites this paper
• First-line eradication of Helicobacter pylori: are the standard triple therapies obsolete? A different perspective.

  2010cites this paper
• Population-based strategies for Helicobacter pylori-associated disease management: a Japanese perspective

  2010cites this paper
• Cost‐Effectiveness of Eradication of Helicobacter pylori in Gastric Cancer Survivors After Endoscopic Resection of Early Gastric Cancer

  2009cites this paper
• Virulence factor genotypes of Helicobacter pylori affect cure rates of eradication therapy

  2009cites this paper
• Identification and molecular characterization of triple- and quadruple-resistant Helicobacter pylori clinical isolates in Germany.

  2009cites this paper
• Recent Trends in the Eradication Rates of Second-Line Quadruple 14 Therapy for Helicobacter Pylori and the Clinical Factors that Potentially Affect the Treatment Outcome.

  2009cites this paper
• Hormones of the gut–brain axis as targets for the treatment of upper gastrointestinal disorders

  2008cites this paper
• Helicobacter pylori vaccine development: optimisation of strategies and importance of challenging strain and animal model.

  2008cites this paper
• Helicobacter pylori eradication therapy: indications, efficacy and safety

  2008cites this paper
• Reversal of Migraine Symptoms by Helicobacter pylori Eradication Therapy in Patients with Hepatitis‐B‐Related Liver Cirrhosis

  2007cites this paper
• Treatment and dosing of Helicobacter pylori infection: when pharmacology meets clinic

  2007cites this paper
• Clarithromycin Resistance, Tumor Necrosis Factor Alpha Gene Polymorphism and Mucosal Inflammation Affect H. pylori Eradication Success

  2007cites this paper
• Helicobacter pylori and Non‐malignant Diseases

  2007cites this paper
• Potential role of the growth hormone secretagogues in clinical practice

  2007cites this paper
• American College of Gastroenterology Guideline on the Management of Helicobacter pylori Infection

  2007cites this paper
• Effect of smoking on failure of H. pylori therapy and gastric histology in a high gastric cancer risk area of Colombia.

  2007cites this paper
• Epidemiology of Helicobacter pylori Infection

  2007cites this paper
• WHAT ARE THE AREAS OF CONTROVERSY FOR WHICH THERE MIGHT BE BENEFIT OF ERADICATING H . PYLORI INFECTION ?

  2007cites this paper
• Helicobacter pylori: testing and treatment

  2007cites this paper
• CagA status and successful eradication of Helicobacter pylori

  2006cites this paper
• CagA status and successful eradication of Helicobacter pylori: authors’ reply

  2006cites this paper
• Effect of CagA Status on H. pylori Eradication

  2006cites this paper